Neurofeedback to Help Smokers Kick the Habit
Experts in toxicology, pulmonary medicine, neuroscience, and behavioral therapy have recently come together to help smokers quit. Preliminary results show that the neuro-feedback intervention protocol can cause lasting changes in the brain cortex as people try to stop smoking. Researchers have designed a specific neuro-feedback intervention protocol to combat addiction.
“Smoking is the largest avoidable cause of lung diseases, morbidity and premature mortality worldwide,” says project coordinator Panagiotis Bamidis. “The purpose of our project is to deliver new knowledge regarding the cost-effectiveness of innovative smoking cessation interventions. This approach should improve the efficiency of public policy strategies aiming to reduce smoker numbers and therefore help to prevent lung diseases.”
Neurofeedback Training for Chemotherapy-Induced Neuropathy Study Receives Award
One of the most-severe side effects of the chemotherapy used in treating cancer patients can be a peripheral neuropathy that is often painful and debilitating for the patient.
“Randomized Controlled Trial of Neurofeedback on Chemotherapy-Induced Peripheral Neuropathy: A Pilot Study,” was published in the June 1, 2017 issue of the journal Cancer. In the study, 100% of the participants completed the program. After treatment, the neurofeedback group showed significantly greater improvement than controls.
Every year, the Foundation for Neurofeedback and Applied Neuroscience presents an award to the authors of the publication that, in its consideration, has most significantly advanced the field of neurofeedback during the preceding year.
“This study shows that neurofeedback can offer an alternative to pain medication which is well accepted by patients.” -Foundation for Neurofeedback and Applied Neuroscience Director Michael O’Bannon
Scientist Uses Neurofeedback to Help Addicts
Last year, Ohio Governor John Kasich called on Ohio Third Frontier to find scientific solutions and technology to fight the opioid epidemic. Through the Ohio Opioid Technology Challenge, which is “a three-phase, prize-based competition to find technology-based solutions that address or improve opioid abuse prevention, treatment and overdose avoidance and response,” technologists are coming together to find solutions to battle the crisis.
Kelly Cashion, a research software engineer at the University of Dayton Research Institute, is applying her neurofeedback research to the opioid challenge. She was one of the $10,000 grant winners.
“People who are suffering from addiction tend to have too many fast brain waves, as opposed to the amount of slow brainwaves, so with neurofeedback you can provide an interface that shows those levels of activity,” Cashion said.